Hybridoma Cell Line 25-D1.16 Producing Monoclonal Anti-H-2Kb/SIINFEKL Complex Antibody

An H-2Kb/OVA hybridoma cell line producing a monoclonal antibody specific for the H-2Kb/SIINFEKL complex (clone 25-D1.16) as described in Immunity 1997 Jun;6(6):715-26 and developed in the laboratory of Dr. Ronald Germain at the National Institute of Allergy and Infectious Diseases.

Potential Commercial Applications:		Competitive Advantages:
A research material that can be used in the development of assays, validation of products or in quality control.		Speed up product development with NIH developed material that has already been tested and validated.

Inventors:

Ronald Germain (NIAID)  ➽ more inventions...

Angel Porgador (NIAID)  ➽ more inventions...


Intellectual Property:
Research Material – Patent protection is not being pursued for this technology. (IC Reference No. 1948-011)

Publications:
Porgador A, et al. PMID 9208844

Licensing Contact:
Daniel Lee, J.D.
Email: daniel.lee5@nih.gov
Phone: 301-761-6327

OTT Reference No: B-006-1999-0
Updated: Dec 4, 2017